Spinal neuropeptide Y Y1 receptor-expressing neurons are a pharmacotherapeutic target for the alleviation of neuropathic pain | Zendy

Tyler S. Nelson | Zendy; Ghanshyam P. Sinha | Zendy; Diogo Francisco da Silva dos Santos | Zendy; Peter Jukkola | Zendy; Pranav Prasoon | Zendy; Michelle K. Winter | Zendy; Kenneth E. McCarson | Zendy; Bret N. Smith | Zendy; Bradley K. Taylor | Zendy

Open Access

Spinal neuropeptide Y Y1 receptor-expressing neurons are a pharmacotherapeutic target for the alleviation of neuropathic pain

Author(s) -

Tyler S. Nelson,

Ghanshyam P. Sinha,

Diogo Francisco da Silva dos Santos,

Peter Jukkola,

Pranav Prasoon,

Michelle K. Winter,

Kenneth E. McCarson,

Bret N. Smith,

Bradley K. Taylor

Publication year - 2022

Publication title -

proceedings of the national academy of sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.011

H-Index - 771

eISSN - 1091-6490

pISSN - 0027-8424

DOI - 10.1073/pnas.2204515119

Subject(s) - sni , neuropathic pain , allodynia , nerve injury , medicine , neuropeptide y receptor , agonist , neuroscience , spinal cord injury , chronic pain , anesthesia , peripheral nerve injury , spinal cord , hyperalgesia , pharmacology , neuropeptide , nociception , receptor , sciatic nerve , chemistry , psychology , biochemistry , hydrolysis , acid hydrolysis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research